CLN-617 is an IL-2/IL-12 fusion protein with a collagen-anchoring domain that induces potent systemic anti-tumor immunity upon intra-tumoral administration

被引：0
|
作者：
Mehta, Naveen K. [1 ]
Li, Bochong [1 ]
Rakhra, Kavya [1 ]
Wittrup, K. Dane [2 ]
Baeuerle, Patrick A. [1 ]
Michaelson, Jennifer S. [1 ]
机构：
[1] Cullinan Oncol, Cambridge, MA USA
[2] Koch Inst Integrat Canc Res, Cambridge, MA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3505
引用
收藏
页数：1
相关论文
共 13 条
  • [1] CLN-617 is a first-in-class fusion protein that retains IL-2 and IL-12 in the injected tumor and potently triggers systemic anti-tumor immunity
    Mehta, Naveen K.
    Rakhra, Kavya
    Meetze, Kristan
    Wittrup, K. Dane
    Michaelson, Jennifer S.
    Baeuerle, Patrick A.
    CANCER RESEARCH, 2023, 83 (07)
  • [2] CLN-617 IS AN INTRATUMORALLY INJECTED AND LOCALLY RETAINED FUSION OF IL-2 AND IL-12 THAT DRIVES SYSTEMIC ANTI-TUMOR ACTIVITY
    Naveen, Mehta
    Rakhra, Kavya
    Meetze, Kristan
    Shapiro, Irina
    Wittrup, Karl
    Baeuerle, Patrick
    Michaelson, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1103 - A1103
  • [3] Anti-tumor effect of GAGomer-mediated intra-tumoral IL-2 expression following systemic administration
    Alpert, Genia
    Altreuter, David
    Anamandla, Sunil
    Birt, Arlyssa
    Cinamon, Guy
    Merimi, Keren Cohen
    Or, Orli Even
    Gefen, Nir
    Gurvich, Nadia
    Gyuris, Jeno
    Lerner, Lorena
    Mondshine, Adi
    Wang, Hong
    CANCER RESEARCH, 2017, 77
  • [4] INTRATUMORAL ADMINISTRATION AND LOCAL RETENTION OF IL-2/IL-12 FUSION PROTEINS DRIVE A POTENT SYSTEMIC ANTI-TUMOR IMMUNE RESPONSE
    Naveen, Mehta
    Li, Bochong
    Wittrup, Dane
    Baeuerle, Patrick
    Michaelson, Jennifer
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A918 - A918
  • [5] Local and Systemic Anti-Tumor Immunity is Induced by Rheoswitch Regulated IL-12 Production after Intra-Tumoral Injection of Adenovirus Vector as well as Vector-Transduced Dendritic Cells
    Herberman, Ronald B.
    Bi, Meixia
    Moreno, Mario
    Butterfield, Lisa
    Buffo, Mary Jo
    Thornton, Mark
    Shafer-Weaver, Kimberly
    MOLECULAR THERAPY, 2011, 19 (07) : 1380 - 1380
  • [6] ZW270, a conditionally masked IL-12 cytokine fusion protein displaying potent anti-tumor activity absent systemic toxicity
    Poffenberger, Maya C.
    Bishop, Jennifer L.
    Blackler, Ryan J.
    Haworth, Kevin G.
    Booth, Steven
    Hanson, Shalla
    Proctor, Jeff R.
    Shao, I-Ting
    Escalante, Nichole K.
    Siddappa, Dayananda
    Smith, Joel
    Anmole, Gursev
    Konomura, Saki
    Dawson, Nicholas A.
    Arrafi, Sifa
    Lau, Desmond
    Rowse, Gerry
    Davies, Rupert H.
    von Kreudenstein, Thomas Spreter
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma
    Zheng, Yanyan
    Lu, Zheng
    Ding, Jiage
    Jiang, Nan
    Wang, Jiawei
    Yang, Jie
    Song, Jingyuan
    Chen, Hongliang
    Fang, Lin
    Li, Huizhong
    Tian, Hui
    Wang, Gang
    Zheng, Junnian
    Chai, Dafei
    CANCERS, 2022, 14 (18)
  • [8] Intratumoral delivery of liposome-anchored anti-CD137 and IL-2 induces highly potent local and systemic anti-tumor immunity while minimizing toxic inflammatory side effects
    Kwong, Brandon
    Liu, Haipeng
    Irvine, Darrell
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [9] AWT020: a novel fusion protein harnessing PD-1 blockade and selective IL-2 Cis-activation for enhanced anti-tumor immunity and diminished toxicity
    Ye, Fan
    Huang, Jianing
    Cheng, Xiaoli
    Chen, Shih Chieh
    Huang, Fang
    Huang, Wen-Chin
    Hua, Botong
    Li, Ella
    Jiang, Jenny
    Lin, Hanna
    Siegel, Matthew
    Liao, Eric
    Wang, Ji
    Yue, Bella
    Shi, Wenli
    Xu, Yanghua
    Wang, Xin
    Wang, Jiaming
    Yan, Yuyuan
    He, Honglin
    Liu, Eugene
    Lu, Binfeng
    Zhong, Ziyang
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [10] Intratumoral Treg cell depletion by local administration of IL-2-Diphteria toxin fusion protein E7777 induces a therapeutic and memory anti-tumor immune response in preclinical models
    Albu, Diana I.
    Ingersoll, Christy
    Huang, Kuan-Chun
    Woodall-Jappe, Mary
    Bao, Xingfeng
    CANCER RESEARCH, 2017, 77
12